Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p.
Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p.
复制标题
DOI:
10.1016/j.bbamem.2013.12.002
复制
发表时间:
2014-03
期刊:
影响因子:
--
通讯作者:
Zhigang Chen;Jingkai Li;Wei Wang;Xiaoxian Guo;Yongquan Li;X. Mao;Xinyu Chen;W. Guan
中科院分区:
文献类型:
--
作者:
Zhigang Chen;Jingkai Li;Wei Wang;Xiaoxian Guo;Yongquan Li;X. Mao;Xinyu Chen;W. Guan
As a mammalian p-glycoprotein homolog, Pdr5p is a major ATP-binding cassette transporter for cellular detoxification in the yeastSaccharomyces cerevisiae. In this study, two novel loss-of-function mutations located adjacent to the ends of the predicted transmembrane helices of Pdr5p were identified. C793F and S1230L mutations considerably impaired the transport activity of Pdr5p without affecting the ATPase activity and the expression level of the protein. Our results demonstrate that the size of residue 793 and the hydrophobicity of residue 1230 are important for Pdr5p efflux function. It reveals that amino acid residues located near the end of transmembrane helix play an important role in drug efflux of Pdr5p. Molecular docking results further suggest that these two single mutations might have disturbed interactions between the drugs and Pdr5p, preventing the drugs from approaching the intracellular or extracellular portal and subsequently from being exported by Pdr5p.